MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand

MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand
News provided by
Share this article
CEDAR KNOLLS, N.J., Dec. 21, 2020 /PRNewswire/ --
 MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both
Human Nutrition and
Science Biotech to exclusively distribute its 
Fortetropin
® products in Australia and New Zealand. Fortetropin is a proprietary advanced nutrition product developed and owned by MYOS that has been shown in multiple human and veterinary clinical studies to accelerate gains in muscle mass, improve mobility, and enhance recovery from injury.
"We are very pleased to announce our partnership with Science Biotech. In Science Biotech we found a partner that is incredibly passionate about our products. Due to its sporting culture and love of pets, Australia was identified as a key market for us, and we couldn't be happier with the fit we've found with Science Biotech," said MYOS CEO Joseph Mannello. "This is the latest in a series of international distribution partnerships that we've recently been able to establish as we continue to grow our business globally."

Related Keywords

Australia ,New Zealand ,Australians ,Joanne Goodford ,Joseph Mannello ,Animal Health ,Drug Administration ,Physician Muscle Health Formula ,Muscle Company ,Human Nutrition ,Science Biotech ,Science Biotech Director Alicia ,Muscle Formula ,Cedar Knolls ,Physician Muscle Health ,Vet Strength ,ஆஸ்திரேலியா ,புதியது ஜீலாந்து ,ஆஸ்திரேலியர்கள் ,விலங்கு ஆரோக்கியம் ,மருத்துவர் தசை ஆரோக்கியம் சூத்திரம் ,தசை நிறுவனம் ,மனிதன் ஊட்டச்சத்து ,அறிவியல் பயோடெக் ,அறிவியல் பயோடெக் இயக்குனர் அலிசியா ,தசை சூத்திரம் ,சிடார் நோல்ல்ஸ் ,மருத்துவர் தசை ஆரோக்கியம் ,கால்நடை வலிமை ,